Illumina to Announce First Quarter 2022 Financial Results on Thursday, May 5, 2022PRNewsWire • 04/14/22
Illumina Expands Access to Genomics in Latin America through New State-of-the-Art Solution CenterPRNewsWire • 04/12/22
Illumina Accelerator Invests in Seven Omics Startups Advancing Breakthrough Therapeutics, Diagnostics, DNA Storage, Mental Wellness, and Sustainable Foods ApplicationsPRNewsWire • 03/16/22
Illumina Unveils Groundbreaking Comprehensive Genomic Profiling Test for Cancer in EuropePRNewsWire • 03/15/22
Illumina, Inc. (ILMN) CEO Francis deSouza Presents at Cowen Health Care Conference (Transcript)Seeking Alpha • 03/08/22
Exclusive-Illumina remedies on Grail bid 'yet to convince' Eu antitrust regulators, sources sayReuters • 03/03/22
GRAIL and Point32Health Collaborate to Offer Galleri® Multi-Cancer Early Detection Blood TestPRNewsWire • 02/15/22
Illumina's (ILMN) CEO Francis deSouza on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/11/22